Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins

Gastroenterology

Volumn 139, Issue 3, 2010, Pages 965-974

  Dahari, Harel ^a   Feinstone, Stephen M ^b   Major, Marian E ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Correlates of Protection; ELISPOT Responses; Viral Kinetics

Indexed keywords

RNA; VIRUS VACCINE; HEPATITIS C ANTIBODY; HEPATITIS VACCINE; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CHIMPANZEE; DRUG CLEARANCE; DRUG EFFICACY; HEPATITIS C; HEPATITIS C VIRUS; IMMUNE RESPONSE; NONHUMAN; OUTCOME ASSESSMENT; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN STRUCTURE; T LYMPHOCYTE; VACCINATION; VIREMIA; VIRUS REPLICATION; ANIMAL; BLOOD; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEPACIVIRUS; IMMUNOLOGY; INNATE IMMUNITY; KINETICS; META ANALYSIS; PAN TROGLODYTES; VIROLOGY; VIRUS LOAD;

ANIMALS; DISEASE MODELS, ANIMAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; IMMUNITY, INNATE; KINETICS; PAN TROGLODYTES; RNA, VIRAL; T-LYMPHOCYTES; VIRAL HEPATITIS VACCINES; VIRAL LOAD; VIRAL STRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 77956168246     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.05.077     Document Type: Article

References (71)

1. R. Bartenschlager, M. Frese, and T. Pietschmann Novel insights into hepatitis C virus replication and persistence Adv Virus Res 63 2004 71 180
2. D. Moradpour, F. Penin, and C.M. Rice Replication of hepatitis C virus Nat Rev Microbiol 5 2007 453 463
3. M.J. Alter, D. Kruszon-Moran, and O.V. Nainan The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 1999 556 562
4. T.J. Liang, B. Rehermann, and L.B. Seeff Pathogenesis, natural history, treatment, and prevention of hepatitis C Ann Intern Med 132 2000 296 305
5. National Institutes of Health Consensus Development Conference statement: management of hepatitis C: 2002. June 1012, 2002 Hepatology 36 2002 S3 S20
6. M.P. Stumpf, and O.G. Pybus Genetic diversity and models of viral evolution for the hepatitis C virus FEMS Microbiol Lett 214 2002 143 152
7. S. Duffy, L.A. Shackelton, and E.C. Holmes Rates of evolutionary change in viruses: patterns and determinants Nat Rev Genet 9 2008 267 276
8. A.U. Neumann, N.P. Lam, and H. Dahari Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy Science 282 1998 103 107
9. P. Simmonds, J. Bukh, and C. Combet Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes Hepatology 42 2005 962 973
10. D. Murphy, J. Chamberland, and R. Dandavino A new genotype of hepatitis C virus originating from central Africa Hepatology 46 2007 623A
11. A.L. Erickson, Y. Kimura, and S. Igarashi The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes Immunity 15 2001 883 895
12. D.G. Bowen, and C.M. Walker Mutational escape from CD8+ T-cell immunity: HCV evolution, from chimpanzees to man J Exp Med 201 2005 1709 1714
13. L. Uebelhoer, J.H. Han, and B. Callendret Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness PLoS Pathog 4 2008 1 15
14. A.J. Weiner, H.M. Geysen, and C. Christopherson Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections Proc Natl Acad Sci U S A 89 1992 3468 3472
15. Y.K. Shimizu, M. Hijikata, and A. Iwamoto Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses J Virol 68 1994 1494 1500
16. T. von Hahn, J.C. Yoon, and H. Alter Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo Gastroenterology 132 2007 667 678
17. A. Grakoui, N.H. Shoukry, and D.J. Woollard HCV persistence and immune evasion in the absence of memory T cell help Science 302 2003 659 662
18. M.E. Major, K. Mihalik, and M. Puig Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge J Virol 76 2002 6586 6595
19. M. Nascimbeni, E. Mizukoshi, and M. Bosmann Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees J Virol 77 2003 4781 4793
20. N.H. Shoukry, A. Grakoui, and M. Houghton Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection J Exp Med 197 2003 1645 1655
21. R. Thimme, J. Bukh, and H.C. Spangenberg Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease Proc Natl Acad Sci U S A 99 2002 15661 15668
22. M. Puig, K. Mihalik, and M.Y. Yu Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay J Virol Methods 105 2002 253 263
23. R.E. Engle, R.S. Russell, and R.H. Purcell Development of a TaqMan assay for the six major genotypes of hepatitis C virus: comparison with commercial assays J Med Virol 80 2008 72 79
24. X. Forns, R. Thimme, and S. Govindarajan Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees Proc Natl Acad Sci U S A 97 2000 13318 13323
25. B.D. Lindenbach, P. Meuleman, and A. Ploss Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro Proc Natl Acad Sci U S A 103 2006 3805 3809
26. T. Wakita, T. Pietschmann, and T. Kato Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat Med 11 2005 791 796
27. J.W. Youn, S.H. Park, and D. Lavillette Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee Hepatology 42 2005 1429 1436
28. J.W. Youn, Y.W. Hu, and N. Tricoche Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus J Virol 82 2008 10896 10905
29. M.E. Major, H. Dahari, and K. Mihalik Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees Hepatology 39 2004 1709 1720
30. D.J. Woollard, A. Grakoui, and N.H. Shoukry Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee Hepatology 38 2003 1297 1306
31. A. Folgori, S. Capone, and L. Ruggeri A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees Nat Med 12 2006 190 197
32. C. Rollier, E. Depla, and J.A. Drexhage Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response J Virol 78 2004 187 196
33. X. Forns, P.J. Payette, and X. Ma Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV Hepatology 32 2000 618 625
34. G.A. Elmowalid, M. Qiao, and S.H. Jeong Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees Proc Natl Acad Sci U S A 104 2007 8427 8432
35. J. Bukh, C.L. Apgar, and R. Engle Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool J Infect Dis 178 1998 1193 1197
36. Z. Hong, M. Beaudet-Miller, and R.E. Lanford Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees Virology 256 1999 36 44
37. M. Yanagi, M. St Claire, and M. Shapiro Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo Virology 244 1998 161 172
38. A. Sakai, S. Takikawa, and R. Thimme In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells J Virol 81 2007 7208 7219
39. J.C. Meunier, R.E. Engle, and K. Faulk Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1 Proc Natl Acad Sci U S A 102 2005 4560 4565
40. T. Kato, Y. Choi, and G. Elmowalid Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation Hepatology 48 2008 732 740
41. S. Kamili, K. Krawczynski, and K. McCaustland Infectivity of hepatitis C virus in plasma after drying and storing at room temperature Infect Control Hosp Epidemiol 28 2007 519 524
42. A.M. Prince, J.M. Pawlotsky, and A. Soulier Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections J Viral Hepat 11 2004 236 242
43. K. Katayama, J. Kumagai, and Y. Komiya Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission Intervirology 47 2004 57 64
44. M.T. Shata, N. Tricoche, and M. Perkus Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees Virology 314 2003 601 616
45. M. Thomson, M. Nascimbeni, and M.B. Havert The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity J Virol 77 2003 862 870
46. M. Thomson, M. Nascimbeni, and S. Gonzales Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus Gastroenterology 121 2001 1226 1233
47. J. Bukh, T. Pietschmann, and V. Lohmann Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees Proc Natl Acad Sci U S A 99 2002 14416 14421
48. S.E. Bassett, B. Guerra, and K. Brasky Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection Hepatology 33 2001 1479 1487
49. J. Bukh, R. Thimme, and J.C. Meunier Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain J Virol 82 2008 8183 8195
50. R.E. Lanford, B. Guerra, and D. Chavez Cross-genotype immunity to hepatitis C virus J Virol 78 2004 1575 1581
51. A.M. Prince, B. Brotman, and D.H. Lee Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model J Infect Dis 192 2005 1701 1709
52. S. Coates, Q.L. Choo, and G. Kuo Protection of chimpanzees against Heterologous 1a viral challenge using a gpE1/gpE2 heterodimer vaccine A.R. Jilbert, E. Grgacic, K. Vickery, Proceedings of the 11th International Symposium on Viral Hepatitis and Liver Disease 2004 Australian Center for Hepatitis 118 123 Virology
53. Q.L. Choo, G. Kuo, and R. Ralston Vaccination of chimpanzees against infection by the hepatitis C virus Proc Natl Acad Sci U S A 91 1994 1294 1298
54. M. Esumi, T. Rikihisa, and S. Nishimura Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees Arch Virol 144 1999 973 980
55. H. Dahari, M. Major, and X. Zhang Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production Gastroenterology 128 2005 1056 1066
56. S.H. Mehta, A. Cox, and D.R. Hoover Protection against persistence of hepatitis C Lancet 359 2002 1478 1483
57. W.O. Osburn, B.E. Fisher, and K.A. Dowd Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection Gastroenterology 138 2009 315 324
58. D.G. Bowen, and C.M. Walker Adaptive immune responses in acute and chronic hepatitis C virus infection Nature 436 2005 946 952
59. R.J. Duerst, and L.A. Morrison Innate immunity to herpes simplex virus type 2 Viral Immunol 16 2003 475 490
60. D.N. Forthal, G. Landucci, and R. Haubrich Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients J Infect Dis 180 1999 1338 1341
61. C. Karnasuta, R.M. Paris, and J.H. Cox Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand Vaccine 23 2005 2522 2529
62. S. Rerks-Ngarm, P. Pitisuttithum, and S. Nitayaphan Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand N Engl J Med 361 2009 2209 2220
63. M. Puig, K. Mihalik, and J.C. Tilton CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus Hepatology 44 2006 736 745
64. I. Zubkova, Y.H. Choi, and E. Chang T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation Vaccine 27 2009 2594 2602
65. H. Dahari, J.E. Layden-Almer, and E. Kallwitz A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease Gastroenterology 136 2009 1402 1409
66. H.J. Alter, and L.B. Seeff Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome Semin Liver Dis 20 2000 17 35
67. L.B. Seeff Natural history of chronic hepatitis C Hepatology 36 2002 S35 S46
68. K.E. Corey, J. Mendez-Navarro, and E.C. Gorospe Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis J Viral Hepat 17 2010 201 207
69. M.E. Major, K. Mihalik, and J. Fernandez Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus J Virol 73 1999 3317 3325
70. C.S. Rollier, G. Paranhos-Baccala, and E.J. Verschoor Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity Hepatology 45 2007 602 613
71. M. Puig, M.E. Major, and K. Mihalik Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection Vaccine 22 2004 991 1000